Skip to main content
Log in

Healing of chronic gastroduodenal ulcerations by antacids

Role of prostaglandins and epidermal growth factor

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Antacids show gastroprotective action against various irritants in experimental animals and enhance the healing of chronic gastroduodenal ulcers in humans but the mechanisms of these effects are unknown. The present study was designed to determine whether prostaglandin (PG) and epidermal growth factor (EGF), which also have protective and antiulcer properties, contribute to the action of antacids on rat's stomach. It was found that Maalox 70 and its active component, Al(OH)3, enhance significantly the healing of chronic gastric and duodenal ulcers observed during 7 and 14 days after their induction. Pretreatment with indomethacin caused a significant prolongation of ulcer healing, and this was accompanied by a significant reduction in PG and EGF formation, suggesting that both factors may be involved in ulcer healing. Maalox and Al(OH)3 failed to prevent the suppression of PG by indomethacin but were equally effective in ulcer healing in rats without and with indomethacin administration, suggesting that endogenous PG may not play any important role in the healing process by these drugs. Removal of salivary glands, the major source of EGF, also prolonged ulcer healing but, again, Maalox was as effective in ulcer healing as in rats with intact salivary glands. Our findings that Maalox at pH above 3.0 binds significant amounts of EGF, enhances the binding of EGF to the ulcer area, and stimulates mucosal growth, suggest that EGF may be involved in ulcer healing; however, because antacids are also effective after sialoadenectomy, EGF does not seem to be the major factor in ulcer healing by these drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Engler H, Szelenyi I: Tierexperimentelle underschungen zur antiulzerogenen wirung vershciedener antazida. Therapiewoche 30:5743–5746, 1980

    Google Scholar 

  2. Szelenyi I, Postius S, Engler H: Evidence for a functional cytoprotective effect produced by antacids in the rat stomach. Eur J Pharmacol 88:403–406, 1983

    PubMed  Google Scholar 

  3. Tarnawski A, Hollander D, Cummings D, Krause WJ, Gergely H, Zipser RD: Are antacids acid neutralisers only? Histologic, ultrastructural and functional changes in normal gastric mucosa induced by antacids. Gastroenterology 86:1276–1281, 1984

    Google Scholar 

  4. Domschke W, Hagel J, Puppin H, Kaduk B: Antacids and gastric mucosal protection. Scand J Gastroenterol 21(suppl 125):144–149, 1986

    Google Scholar 

  5. Tarnawski A, Hollander D, Gergely H, Stachura J: Comparison of antacid, sucralfate, cimetidine and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med 79(suppl 26):19–23, 1985

    Google Scholar 

  6. Hollander D, Tarnawski A, Gergely H: Protection against alcohol-induced gastric mucosal injury by aluminium/containing compounds-sucralfate, antacids and aluminum sulfate. Scand J Gastroenterol 21(suppl 125):151–153, 1986

    PubMed  Google Scholar 

  7. Priebe JH, Skillman JJ, Bushnell LS, Long PC, Silen W: Antacid versus cimetidine in preventing acute gastrointestinal bleeding: A randomized trial in 75 critically ill patients. N Engl J Med 302:426–430, 1980

    PubMed  Google Scholar 

  8. Peterson WL, Sturdevant AL, Frankl HD, Richardson ChT, Isenberg JI, Elashoff JD, Stones JQ, Gross RA, McCallum RW, Fordtran JS: Healing of duodenal ulcer with an antacid regimen. N Engl J Med 297:341–345, 1977

    PubMed  Google Scholar 

  9. Ippoliti AF, Sturdevant RAL, Isenberg JI, et al: Cimetidine versus intensive antacid therapy for duodenal ulcer. A multicenter trial. Gastroenterology 74:393–395, 1978

    PubMed  Google Scholar 

  10. Fedeli G, Anti M, Rapaccini GL, De Vitis I, Butti A, Civelo IM: A controlled study comparing cimetidine treatment to an intensive antacid regimen in the therapy of uncomplicated duodenal ulcer. Dig Dis Sci 24:758–762, 1979

    PubMed  Google Scholar 

  11. Lam SK, Lam KC, Lai CL, et al: Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology 76:315–322, 1979

    PubMed  Google Scholar 

  12. Berstad A, Rydning A, Aaland E, Kolstad B, Frislid K, Asseth J: Controlled clinical trial of duodenal ulcer healing with antacid tablets. Scand J Gastroenterol 17:953–959, 1982

    PubMed  Google Scholar 

  13. Kumar N, Vij JC, Karol A, Anand BS: Controlled therapeutic trial to determine the optimum dose of antacids in duodenal ulcer. Gut 25:1199, 1984

    PubMed  Google Scholar 

  14. Faizallah R, De Haan HA, Krasner N, Walker RJ, Morris AI, Calam MJ, Budgett DA: Is there a place in the United Kingdom for intensive antacid treatment for chronic peptic ulceration? Br Med J 289:869–871, 1984

    Google Scholar 

  15. Laurisen K, Bytzer P, Hansen J, Bekker C, Rask-Madsen J: Comparison of ranitidine and high-dose antacid in the treatment of prepyloric or duodenal ulcer. A double-blind controlled trial. Scand J Gastroenterol 20:123–138, 1985

    PubMed  Google Scholar 

  16. Bianchi-Porro G, Parente F, Lazzaroni M, Baroni S, Panza E: Medium-dose antacids versus cimetidine in the short-term treatment of duodenal ulcer. J Clin Gastroenterol 8:141–154, 1986

    PubMed  Google Scholar 

  17. Bianchi Porro G, Lazzaroni M, Pace F, Petrillo M: Long-term low dose antacid versus cimetidine therapy in the treatment of duodenal ulcer recurrence. Scand J Gastroenterol 21:1144–1146, 1986

    PubMed  Google Scholar 

  18. Rynding A, Weberg R, Lange O, Berstad A: Healing of benign gastric ulcer with low-dose antacids and fiber diet. Gastroenterology 91:56–61, 1986

    PubMed  Google Scholar 

  19. Isenberg JI, Peterson WI, Elashoff JD, et al: Healing of benign gastric ulcer with low-dose antacid and cimetidine. A double-blind, randomized, placebo-controlled trial. N Engl J Med 308:1319–1324, 1983

    PubMed  Google Scholar 

  20. Pace F, Broker HJ, Caspary W, Feurle G, Fimmel CJ, Hackenberg K, Hammer B, Holtermuller KH, Hotz J: Therapy of stomach ulcer with low-dose antacid gel and cimetidine. A multicenter double-blind study. Dtsch Med Wochenschr 11:183–187, 1985

    Google Scholar 

  21. Berstad A, Weberg R: Antacids for peptic ulcer: Do we have anything better? Scand J Gastroenterol 21:144–147, 1986

    Google Scholar 

  22. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 77:433–443, 1979

    PubMed  Google Scholar 

  23. Konturek SJ, Radecki T, Brzozowski T, Piastucki I, Dembinski A, Dembinska-Kiec A, Zmuda A, Gryglewski R, Gregory H: Gastric cytoprotection by epidermal growth factor. Role of endoengous prostaglandins and DNA synthesis. Gastroenterology 81:438–443, 1981

    PubMed  Google Scholar 

  24. Skov Olsen P, Poulssen SS, Kirkegaard P, Nexo E: Role of submandibular saliva and epidermal growth factor in gastric cytoprotection. Gastroenterology 87:103–108, 1984

    PubMed  Google Scholar 

  25. Skov Olsen P, Poulsen SS, Therkelsen K, Nexo E: Effect of sialoadenectomy and synthetic human urogastrone on healing of chronic gastric ulcers in rats. Gut 27:1443–1449, 1986

    PubMed  Google Scholar 

  26. Skov Olsen P, Poulsen SS, Therkelsen K, Nexo E: Oral administration of synthetic human urogastrone promotes healing of chronic duodenal ulcers in rats. Gastroenterology 90:911–917, 1986

    PubMed  Google Scholar 

  27. Konturek SJ, Stachura J, Radecki T, Drozdowicz D, Brzozowski T: Cytoprotective and ulcer healing properties of prostaglandin E2in rats. Digestion 38:103–113, 1987

    PubMed  Google Scholar 

  28. Konturek SJ, Dembinski A, Warzecha Z, Bielanski W, Brzozowski T, Drozdowicz D: Epidermal growth factor (EGF) in the gastroprotective and ulcer healing actions of colloidal bismuth subcitrate (De-Nol) in rats. Gut 29:894–902, 1986

    Google Scholar 

  29. Okabe S, Pfeiffer CJ, Roth JLA: A method for experimental, penetrating gastric and duodenal ulcers in rats. Am J Dig Dis 16:277–284, 1971

    PubMed  Google Scholar 

  30. Debminski A, Gregory H, Konturek SJ, Polanski M. Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (London) 325:35–42, 1982

    Google Scholar 

  31. Konturek SJ, Radecki T, Brzozowski T, Drozdowicz D, Piastucki I, Muramatsu M, Tanaka M, Aihara H: Antiulcer and gastroprotective effects of solon, a synthetic flavonoid derivative of sophoradain. Role of endogenous prostaglandins. Eur J Pharmacol 125:185–192, 1986

    PubMed  Google Scholar 

  32. Konturek SJ, Brzozowski T, Dembinski A, Warzecha Z, Konturek PK, Yanaihara N: Interaction of growth hormone-releasing factor and somatostatin on ulcer healing and mucosal growth in rats. Role of gastrin and epidermal growth factor. Digestion 41:121–128, 1988

    PubMed  Google Scholar 

  33. Vantrappen G, Rutgeerts P, Broekart L, Janssens J: Randomized open controlled trial of colloidal bismuth subcitrate tablets and cimetidine in the treatment of duodenal ulcer. Gut 21:329–353, 1981

    Google Scholar 

  34. Kang JY, Piper DW: Cimetidine and colloidal bismuth in treatment of chronic duodenal ulcer. Digestion 23:73–79, 1982

    PubMed  Google Scholar 

  35. Hamilton I, Worsley BW, O'Connor HJ, Axon ATR: The effects of tripotassium dicitratobismuthate tablets or cimetidine in the treatment of duodenal ulcer. Gut 24:1148–1151, 1983

    PubMed  Google Scholar 

  36. Clain JE, Malagelada JR, Chadwick VS: Binding propertiesin vitro of antacids for conjugated bile acids. Gastroenterology 73:556–559, 1977

    PubMed  Google Scholar 

  37. Reimann HJ, Schmidt U, Wendt P, Dorsch W, von Sanden H, von der Ohe M, Lewin J, Ultsch B: Die Wirkung von Antazida auf den Gehalt von Gewebshistamin und Prostaglandinen (PGE2) in der Magenmukoza. Fortschr Med 102:47–50, 1984

    Google Scholar 

  38. Preclik G, Stange EF, Gerber K, Fetzer G, Harn H, Ditchuneit H: Stimulation of mucosal prostaglandin synthesis in human stomach and duodenum by antacid treatment. Gut 30:148, 1989

    PubMed  Google Scholar 

  39. Hawkey CJ, Walt RP: Prostaglandins for peptic ulcer promise unfulfilled. Lancet 2:1084–1086, 1986

    PubMed  Google Scholar 

  40. Wang JY, Yamaski S, Takeuchi K, Okabe S: Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 96:393–402, 1989

    PubMed  Google Scholar 

  41. Yamamoto O, Okada Y, Okabe S: Effects of a proton pump inhibitor omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig Dis Sci 29:394–401, 1984

    PubMed  Google Scholar 

  42. Konturek SJ, Dembinski A, Warzecha Z, Brzozowski T, Gregory H: Role of epidermal growth factor in healing of chronic gastroduodenal ulcers in rats. Gastroenterology 94:1300–1307, 1988

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konturek, S.J., Brzozowski, T., Drozdowicz, D. et al. Healing of chronic gastroduodenal ulcerations by antacids. Digest Dis Sci 35, 1121–1129 (1990). https://doi.org/10.1007/BF01537585

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01537585

Key words

Navigation